Kanishk Kharbanda Appointed As Director Of International Business
ncarol.com/10122157

MORRISVILLE, N.C. - ncarol.com -- BioMedomics, Inc. has announced that Mr. Kanishk Kharbanda has been appointed as Director of International Business with immediate effect. In his new role, Mr. Kharbanda will be responsible for the success of all outside-US operations which include sales, marketing, regulatory, logistics and manufacturing strategy. He will also be responsible for driving sales in Asia Pacific and EU regions.

With over 17 years' experience in international healthcare business, Kanishk has proven himself a visionary leader, strategic thinker, with a stellar reputation in the industry. Prior to joining BioMedomics Kanishk worked in business strategy consulting, market access, and public health program management in top companies and non-profit foundations. Kanishk earned his Master's in Business degree from the renowned Duke University's Fuqua School of Business and Bachelor's in Engineering degree from Manipal Institute of Technology.

More on ncarol.com

• IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
• Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
• EnergyStrat Launches Global LNG Risk Outlook 2025–2030
• LTL Claims Ratio Index – Update 3Q25
• Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)

"We are extremely fortunate and honored to have Kanishk as part of our Leadership Team", said Brad Heidinger, COO of BioMedomics. "Kanishk has been a great asset to our company in his previous role and I know he will continue to be impactful as our Director of International Business. He has an unquestionable skill set and is a real leader that brings both innovation and expertise.  He adds tremendous depth and value to our company."

"With our rich product pipeline and growing international customer base, we're at an inflection point as a company." said Kharbanda. "This brings ample challenges and opportunities - to grow and to streamline in lock step while delivering best-in-class customer experiences. A balancing act we're going to take head on."

For more information about BioMedomics, visit http://www.biomedomics.com